tolbutamide has been researched along with Cardiac Hypertrophy in 1 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziegelasch, HJ | 1 |
| Ziegelasch, H | 1 |
| Mauve, L | 1 |
1 other study available for tolbutamide and Cardiac Hypertrophy
| Article | Year |
|---|---|
[Incidence of pathological ECG findings, hypertension and obesity in diabetic patients depending on their mode of therapy].
Topics: Cardiomegaly; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Electrocardiograph | 1981 |